Your browser doesn't support javascript.
loading
Population Pharmacokinetics of Brentuximab Vedotin in Patients With CD30-Expressing Hematologic Malignancies.
Li, Hong; Han, Tae H; Hunder, Naomi N; Jang, Graham; Zhao, Baiteng.
Affiliation
  • Li H; Seattle Genetics, Inc., Bothell, WA, USA.
  • Han TH; Seattle Genetics, Inc., Bothell, WA, USA.
  • Hunder NN; Seattle Genetics, Inc., Bothell, WA, USA.
  • Jang G; Seattle Genetics, Inc., Bothell, WA, USA.
  • Zhao B; Seattle Genetics, Inc., Bothell, WA, USA.
J Clin Pharmacol ; 57(9): 1148-1158, 2017 09.
Article in En | MEDLINE | ID: mdl-28513851
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Ki-1 Antigen / Immunoconjugates / Hematologic Neoplasms / Models, Biological / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Ki-1 Antigen / Immunoconjugates / Hematologic Neoplasms / Models, Biological / Antineoplastic Agents Type of study: Clinical_trials / Prognostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharmacol Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom